SCHEMBL31347433

SCHEMBL31347433

CCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC(O)CO)OCCCCCCCCCCCCCCCCC

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 9/20 0.68
▸ LPAR3 Q9UBY5 9/20 0.68
▸ LPAR2 Q9HBW0 6/20 0.60
▸ USP2 O75604 1/20 0.59
▸ LPAR5 Q9H1C0 6/20 0.58
▸ PLA2G2C Q5R387 1/20 0.52
▸ P2RY10 O00398 1/20 0.51
▸ LPAR6 P43657 5/20 0.50
▸ LPAR4 Q99677 5/20 0.50
▸ SELP P16109 1/20 0.48
▸ AKT1 P31749 3/20 0.47
▸ AKT2 P31751 3/20 0.47
▸ AKT3 Q9Y243 3/20 0.47
▸ PIK3R1 P27986 2/20 0.47
▸ PIK3CA P42336 2/20 0.47
▸ PLCG2 P16885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31347418 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL31347412 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL31347445 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL31347450 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL3487492 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL31347451 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL31347443 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL31347421 1.00 LPAR1 (0.68) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL29253735 0.99 LPAR1 (0.66) LPAR1LPAR3LPAR2USP2LPAR5
SCHEMBL3486664 0.93 P2RY10 (0.62) LPAR1LPAR3LPAR2USP2LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746853-A1 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) 2026-05-27 — — EP claimed
WO-2025021835-A9 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-11-06 — — WO claimed
WO-2025021835-A1 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-30 — — WO claimed
WO-2025021286-A1 A DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-30 — — WO claimed
EP-4746853-A1 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. (DE) 2026-05-27 — — EP disclosed
WO-2025021835-A9 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-11-06 — — WO disclosed
WO-2025021835-A1 A LIPID DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-30 — — WO disclosed
WO-2025021286-A1 A DRUG DELIVERY SYSTEM FOR INCREASED ENDOSOMAL ESCAPE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-01-30 — — WO disclosed
Send feedback